Welcome to our dedicated page for AFLAC SEC filings (Ticker: AFL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Aflac Incorporated's SEC filings document a supplemental health and life insurer with reportable operations in Japan and the United States. Form 8-K reports furnish quarterly and annual results, supplemental earnings materials, investor presentations and Regulation FD disclosures tied to segment performance, premiums, investment income, dividends and share repurchases.
Proxy and annual-meeting filings cover board elections, executive compensation votes, auditor ratification, shareholder proposals and common-stock voting matters. Other material-event filings describe financing arrangements, including pre-capitalized trust securities and contingent senior-note funding, as well as cybersecurity incident disclosures, operational continuity, customer information risks, governance controls and public-company reporting obligations.
Aflac executive Steven Kent Beaver, EVP and CFO of Aflac Japan, reported equity awards and a related tax-withholding share disposition in Aflac Inc. common stock. On February 10, 2026, he acquired 11,032 and separately 2,158 common shares at $0 per share as grants under Aflac’s Long-Term Incentive Plan. On the same date, 3,646 shares were disposed of at $113.20 per share to satisfy tax obligations. After these transactions, he directly owned 47,912 Aflac common shares.
Aflac Inc. executive Max Broden, Sr. EVP and CFO, reported equity compensation and related tax transactions in company stock. On February 10, 2026, he acquired 49,458 shares of common stock at $0 under the Aflac Incorporated Long-Term Incentive Plan, increasing his direct holdings to 169,230 shares.
That same day, 21,854 shares of common stock were disposed of at $113.20 per share to satisfy tax obligations, leaving 147,376 directly held shares. Indirectly through his spouse, he reported an award of 65 shares on February 10, 2026 (total 405 indirect shares) and a tax-withholding disposition of 10 shares at $116.25 per share on February 11, 2026, leaving 395 indirect shares.
Aflac Inc. Executive Vice President Bradley E. Dyslin reported equity compensation and related tax withholding transactions in company stock. On February 10, 2026, he acquired 28,857 shares of Aflac common stock at $0 per share as a grant under the Aflac Incorporated Long-Term Incentive Plan. On the same date, 13,446 shares were disposed of at $113.2 per share to cover tax obligations, leaving him with 44,677 shares of Aflac common stock held directly after these transactions.
Aflac officer Masatoshi Koide acquired 30,861 shares of Aflac common stock on February 10, 2026 through a grant under the Aflac Incorporated Long-Term Incentive Plan at $0 per share, bringing his directly held stake to 101,853 shares after the transaction.
Aflac executive Charles D. Lake II, Chairman & Rep. Director, ALIJ, acquired 27,865 shares of Aflac common stock on February 10, 2026 through a grant under the Aflac Incorporated Long-Term Incentive Plan (as amended and restated February 14, 2017).
The shares were granted at a stated price of $0 per share, bringing his directly held beneficial ownership to 77,827 common shares. He also beneficially owns 1,320 common shares indirectly through a 401(k) plan.
Broden Max reported disposition transactions in a Form 4 filing for AFL. The filing lists transactions totaling 2,290 shares at a weighted average price of $113.20 per share. Following the reported transactions, holdings were 119,772 shares.
Aflac Inc. senior vice president and chief accounting officer Robin Littrell Blackmon reported a tax-withholding disposition of company stock. On February 9, 2026, 290 shares of Aflac common stock were surrendered at $113.20 per share to cover taxes, leaving 6,807 shares owned directly.
Aflac Senior Executive Vice President and Chief Financial Officer Max Broden reported a sale of company stock. On February 6, 2026, he sold 13,000 shares of Aflac common stock at a weighted average price of $117.665 per share in multiple transactions priced between $117.37 and $118.115.
After this sale, Broden directly beneficially owned 122,062 shares of Aflac common stock. In addition, there are 340 shares reported as indirectly owned through his spouse.
Aflac Inc filed a Form 13F reporting institutional holdings. The filing lists 3 information-table entries with a total value of $138,714,822 and notes 1 other included manager, Aflac Asset Management LLC. The report was signed by Robin Blackmon on 02-06-2026.
Aflac Incorporated has a Form 144 notice indicating a planned sale of 13,000 shares of its common stock through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $1,529,646.00 and an approximate sale date of February 6, 2026.
The shares were acquired from the issuer as restricted stock vesting between 2018 and 2021 as compensation, in multiple small grants. The filing notes that 524,113,917 shares of common stock were outstanding, providing scale for the proposed sale.